These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29202720)

  • 1. High-precision radiotherapy of motor deficits due to metastatic spinal cord compression (PRE-MODE): a multicenter phase 2 study.
    Rades D; Cacicedo J; Conde-Moreno AJ; Doemer C; Dunst J; Lomidze D; Segedin B; Olbrich D; Holländer NH
    BMC Cancer; 2017 Dec; 17(1):818. PubMed ID: 29202720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiotherapy for metastatic spinal cord compression with increased radiation doses (RAMSES-01): a prospective multicenter study.
    Rades D; Hansen O; Jensen LH; Dziggel L; Staackmann C; Doemer C; Cacicedo J; Conde-Moreno AJ; Segedin B; Ciervide-Jurio R; Rubio-Rodriguez C; Perez-Romasanta LA; Alvarez-Gracia A; Dennis K; Ferrer-Albiach C; Navarro-Martin A; Lopez-Campos F; Jankarashvili N; Janssen S; Olbrich D; Holländer NH
    BMC Cancer; 2019 Nov; 19(1):1163. PubMed ID: 31783816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precision Radiation Therapy for Metastatic Spinal Cord Compression: Final Results of the PRE-MODE Trial.
    Rades D; Cacicedo J; Conde-Moreno AJ; Segedin B; But-Hadzic J; Groselj B; Kevlishvili G; Lomidze D; Ciervide-Jurio R; Rubio C; Perez-Romasanta LA; Alvarez-Gracia A; Olbrich D; Doemer C; Schild SE; Hollaender NH
    Int J Radiat Oncol Biol Phys; 2020 Mar; 106(4):780-789. PubMed ID: 31812719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of 5 × 5 Gy and 10 × 3 Gy for metastatic spinal cord compression using data from three prospective trials.
    Rades D; Cacicedo J; Conde-Moreno AJ; Segedin B; Lomidze D; Ciervide R; Hollaender NH; Schild SE
    Radiat Oncol; 2021 Jan; 16(1):7. PubMed ID: 33413492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A scoring system to predict local progression-free survival in patients irradiated with 20 Gy in 5 fractions for malignant spinal cord compression.
    Rades D; Conde-Moreno AJ; Cacicedo J; Veninga T; Segedin B; Stanic K; Schild SE
    Radiat Oncol; 2018 Dec; 13(1):257. PubMed ID: 30594231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DEGRO practice guidelines for palliative radiotherapy of metastatic breast cancer: bone metastases and metastatic spinal cord compression (MSCC).
    Souchon R; Wenz F; Sedlmayer F; Budach W; Dunst J; Feyer P; Haase W; Harms W; Sautter-Bihl ML; Sauer R;
    Strahlenther Onkol; 2009 Jul; 185(7):417-24. PubMed ID: 19714302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reirradiation of metastases of the central nervous system: part 2-metastatic epidural spinal cord compression.
    Rades D; Simone CB; Wong HCY; Chow E; Lee SF; Johnstone PAS
    Ann Palliat Med; 2024 Jul; 13(4):1141-1149. PubMed ID: 38600819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiotherapy for oligometastatic disease in patients with spinal cord compression (MSCC) from relatively radioresistant tumors.
    Freundt K; Meyners T; Bajrovic A; Basic H; Karstens JH; Adamietz IA; Rudat V; Schild SE; Dunst J; Rades D
    Strahlenther Onkol; 2010 Apr; 186(4):218-23. PubMed ID: 20354660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose escalation of radiotherapy for metastatic spinal cord compression (MSCC) in patients with relatively favorable survival prognosis.
    Rades D; Panzner A; Rudat V; Karstens JH; Schild SE
    Strahlenther Onkol; 2011 Nov; 187(11):729-35. PubMed ID: 22037654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is short-course radiotherapy with high doses per fraction the appropriate regimen for metastatic spinal cord compression in colorectal cancer patients?
    Rades D; Dahm-Daphi J; Rudat V; Schulte R; Stalpers LJ; Veninga T; Hoskin PJ
    Strahlenther Onkol; 2006 Dec; 182(12):708-12. PubMed ID: 17149577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectiveness and toxicity of reirradiation (Re-RT) for metastatic spinal cord compression (MSCC)].
    Rades D; Stalpers LJ; Veninga T; Schulte R; Hoskin PJ; Alberti W
    Strahlenther Onkol; 2005 Sep; 181(9):595-600. PubMed ID: 16170487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative re-irradiation using stereotactic body radiotherapy for metastatic epidural spinal cord compression.
    Ito K; Nihei K; Shimizuguchi T; Ogawa H; Furuya T; Sugita S; Hozumi T; ; Karasawa K
    J Neurosurg Spine; 2018 Sep; 29(3):332-338. PubMed ID: 29905524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors predicting functional outcomes, recurrence-free survival, and overall survival after radiotherapy for metastatic spinal cord compression in breast cancer patients.
    Rades D; Veninga T; Stalpers LJ; Schulte R; Hoskin PJ; Poortmans P; Schild SE; Rudat V
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):182-8. PubMed ID: 16198069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the overall treatment time of radiotherapy with 10 × 3 Gy for outcomes in patients with metastatic spinal cord compression.
    Rades D; Janssen S; Conde-Moreno AJ; Cacicedo J; Metz M; Veninga T; Segedin B; Rudat V; Schild SE
    J Med Imaging Radiat Oncol; 2017 Jun; 61(3):388-393. PubMed ID: 27804231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-course radiotherapy (8 Gy x 2) in metastatic spinal cord compression: an effective and feasible treatment.
    Maranzano E; Latini P; Perrucci E; Beneventi S; Lupattelli M; Corgna E
    Int J Radiat Oncol Biol Phys; 1997 Jul; 38(5):1037-44. PubMed ID: 9276370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation-induced myelopathy in long-term surviving metastatic spinal cord compression patients after hypofractionated radiotherapy: a clinical and magnetic resonance imaging analysis.
    Maranzano E; Bellavita R; Floridi P; Celani G; Righetti E; Lupattelli M; Panizza BM; Frattegiani A; Pelliccioli GP; Latini P
    Radiother Oncol; 2001 Sep; 60(3):281-8. PubMed ID: 11514008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Escalation of radiation dose beyond 30 Gy in 10 fractions for metastatic spinal cord compression.
    Rades D; Karstens JH; Hoskin PJ; Rudat V; Veninga T; Schild SE; Dunst J
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):525-31. PubMed ID: 17141977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression.
    Rades D; Stalpers LJ; Veninga T; Schulte R; Hoskin PJ; Obralic N; Bajrovic A; Rudat V; Schwarz R; Hulshof MC; Poortmans P; Schild SE
    J Clin Oncol; 2005 May; 23(15):3366-75. PubMed ID: 15908648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiotherapy without steroids in selected metastatic spinal cord compression patients. A phase II trial.
    Maranzano E; Latini P; Beneventi S; Perruci E; Panizza BM; Aristei C; Lupattelli M; Tonato M
    Am J Clin Oncol; 1996 Apr; 19(2):179-83. PubMed ID: 8610645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional outcome and survival after radiotherapy of metastatic spinal cord compression in patients with cancer of unknown primary.
    Rades D; Fehlauer F; Veninga T; Stalpers LJ; Basic H; Hoskin PJ; Rudat V; Karstens JH; Schild SE; Dunst J
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):532-7. PubMed ID: 17084539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.